Study of Buprenorphine Sublingual Spray Versus Standard of Care Narcotic Therapy for the Treatment of Post-Operative Pain
Status:
Completed
Trial end date:
2017-11-13
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and tolerability based on the incidence of adverse
experiences of buprenorphine sublingual spray (0.5 milligrams [mg] three times daily [TID])
compared with standard post-operative narcotic therapy in participants with postoperative
pain. Standard post-operative narcotic therapy is defined as morphine intravenous (IV)
injection (4 mg TID) followed by oxycodone hydrochloride tablet (10 mg TID).